Walgreens Ice Blue Pain Relieving

Description

Walgreens Ice Blue Gel is a pain-relieving gel formulated with 2.0% menthol as the active ingredient, designed for topical application. This non-greasy gel provides a cooling sensation and is characterized by its fast-acting properties. The product is packaged in a net weight of 8 ounces (226.8 grams). It is comparable to Mineral Ice in terms of its active ingredient and intended use.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be cleaned prior to the application of the product. For adults and children aged 2 years and older, the product may be applied to the affected area up to 3 to 4 times daily. It is important to note that the product is not recommended for use in children under 2 years of age; consultation with a healthcare professional is advised in such cases.

Contraindications

The product is contraindicated in the following situations:

• Concurrent use with other topical pain relievers is not recommended due to the potential for increased irritation or adverse effects.

• Application alongside heating pads or other heating devices is contraindicated, as this may enhance absorption and lead to increased risk of systemic effects.

• Contact with the eyes must be avoided to prevent irritation or injury.

• Tight bandaging of the application site is contraindicated, as it may restrict circulation and exacerbate local reactions.

• Application to wounds or damaged skin is not advised, as this may increase the risk of systemic absorption and local irritation.

Warnings and Precautions

External use only is indicated for this product. It is imperative that this formulation not be used in conjunction with other topical pain relievers, as this may increase the risk of adverse effects. Additionally, the application of this product alongside heating pads or other heating devices is contraindicated, as it may lead to excessive skin irritation or burns.

Healthcare professionals should advise patients to avoid contact with the eyes to prevent irritation or injury. Bandaging should be done loosely; tight bandages are not recommended as they may impede circulation and exacerbate skin reactions. This product should not be applied to wounds or damaged skin, as this could lead to further complications or delayed healing.

Patients are instructed to discontinue use and consult a healthcare provider if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center contacted at 1-800-222-1222.

For individuals who are pregnant or breastfeeding, it is essential to consult a healthcare professional prior to use to ensure safety for both the mother and child.

Side Effects

Patients using this product should be aware that it is for external use only. It is important to avoid using this product in conjunction with other topical pain relievers or heating devices, such as heating pads. Contact with the eyes should be strictly avoided, and the product should not be applied to wounds or damaged skin. Additionally, patients should refrain from bandaging the area tightly after application.

In the event that the condition worsens, or if symptoms persist for more than 7 days or resolve and then recur within a few days, patients are advised to stop use and consult a healthcare professional.

For those who are pregnant or breastfeeding, it is recommended to seek advice from a health professional prior to use.

This product should be kept out of reach of children. If ingested, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222.

Drug Interactions

Co-administration of this medication with other topical pain relievers is contraindicated due to the potential for increased local irritation or adverse effects. It is advised to avoid the simultaneous use of heating pads or other heating devices, as this may enhance the risk of skin irritation or burns.

Monitoring for signs of local adverse reactions is recommended when this medication is used, particularly in patients who may be using other topical agents or heat sources.

Packaging & NDC

Below are the non-prescription pack sizes of Walgreens Ice Blue Pain Relieving (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this medication; consultation with a healthcare professional is advised. For adults and children aged 2 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers should consider individual circumstances and the specific needs of the patient when making recommendations.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be informed to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using this product, healthcare providers should emphasize the following precautions: Patients should not use the product in conjunction with other topical pain relievers. They should avoid using it with heating pads or other heating devices. It is important to instruct patients to avoid contact with the eyes and to refrain from bandaging the area tightly. Additionally, patients should not apply the product to wounds or damaged skin.

Storage and Handling

The product is supplied in a container that must be kept tightly closed when not in use to maintain its integrity. It should be stored at room temperature, ensuring that it is not exposed to freezing conditions. Additionally, it is crucial to avoid placing the product near heat sources or open flames, as this could compromise its safety and effectiveness.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged 2 years and older being 3 to 4 times daily to the affected area. For children under 2 years of age, it is advised to consult a doctor before use. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Walgreens Ice Blue Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)